ImmunityBio, Inc. (IBRX) Revenue History
ImmunityBio, Inc. (IBRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $44.00K |
| 2017-12-31 | $45.00K |
| 2018-12-31 | $47.00K |
| 2019-12-31 | $43.00K |
| 2020-12-31 | $605.00K |
| 2021-12-31 | $934.00K |
| 2022-12-31 | $240.00K |
| 2023-12-31 | $622.00K |
| 2024-12-31 | $14.74M |
| 2025-12-31 | $113.29M |
How IBRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| QTRX | Quanterix Corporation | $138.90M |
| NRC | National Research Corporation | $137.39M |
| OSUR | OraSure Technologies Inc. | $115.02M |
| AGEN | Agenus Inc. | $114.20M |
| HBIO | Harvard Bioscience Inc. | $86.55M |
These are five companies in the same sector as IBRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get ImmunityBio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("IBRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IBRX | $7.79 | -0.64% | 7.59M |
| 3 | ||||
| 4 | ||||
| 5 |